ClearPoint Neuro (CLPT) Interest Coverage Ratio Growth (1y) (2012 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -6.18% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 66.99% |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -225.43% |
| Mar 31, 2022 | -454.90% |
| Dec 31, 2021 | -118.69% |
| Sep 30, 2021 | -152.56% |
| Jun 30, 2021 | -89.60% |
| Mar 31, 2021 | -357.51% |
| Dec 31, 2020 | -79.07% |
| Sep 30, 2020 | -48.16% |
| Jun 30, 2020 | -49.98% |
| Mar 31, 2020 | 62.47% |
| Dec 31, 2019 | -50.73% |
| Sep 30, 2019 | 12.59% |
| Jun 30, 2019 | 24.29% |
| Mar 31, 2019 | 33.65% |
| Sep 30, 2016 | -17.20% |
| Jun 30, 2016 | 5.01% |
| Mar 31, 2016 | 41.45% |
| Sep 30, 2015 | 32.89% |
| Jun 30, 2015 | -10.26% |
| Mar 31, 2015 | -166.08% |
| Dec 31, 2014 | -336.12% |
| Sep 30, 2014 | 37.80% |
| Jun 30, 2014 | 53.49% |
| Mar 31, 2014 | 1,536.27% |
| Dec 31, 2013 | 62.25% |
| Sep 30, 2013 | -23.00% |
| Jun 30, 2013 | -236.21% |
| Mar 31, 2013 | -103.60% |
| Dec 31, 2012 | -174.34% |
| Sep 30, 2012 | -484.62% |
| Jun 30, 2012 | -103.03% |
| Mar 31, 2012 | 84.29% |